NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,236 Cr | ₹2,247 Cr | ₹1,795 Cr | ₹1,681 Cr | ₹1,448 Cr |
What is the latest Total Expenditure of NATCO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹2,236 Cr |
| Mar2024 | ₹2,247 Cr |
| Mar2023 | ₹1,795 Cr |
| Mar2022 | ₹1,681 Cr |
| Mar2021 | ₹1,448 Cr |
How is Total Expenditure of NATCO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,236 Cr | -0.52 | |
| Mar2024 | ₹2,247 Cr | 25.18 | |
| Mar2023 | ₹1,795 Cr | 6.79 | |
| Mar2022 | ₹1,681 Cr | 16.09 | |
| Mar2021 | ₹1,448 Cr | - | |
Compare Total Expenditure of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,936.0 Cr | 3.5% | 1.1% | -36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,102.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,299.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,753.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,735.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,155.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.5% |
1.1% |
-36.7% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses